Torrent Pharmaceuticals Limited — Others, 29-07-2025: Shareholders meeting

Torrent Pharmaceuticals' 52nd Annual General Meeting addressed significant strategic moves. Shareholders confirmed an interim dividend of ₹26.00 per share and declared a final dividend of ₹6.00 per share for FY25. The company secured approval to issue equity shares, convertible bonds, or debentures, setting the stage for potential future capital raising. Crucially, borrowing limits were substantially enhanced from ₹15,000 Crore to ₹26,000 Crore, providing greater financial flexibility for future growth and acquisitions. Aman Mehta was also appointed as the new Managing Director, marking a key leadership development. Other approvals included adopting financial statements and enhancing limits for loans and investments.